Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
The broad antipseudomonal spectrum of the carbapenem BMS-181139 includes clinical strains and laboratory mutants of Pseudomonas aeruginosa that are resistant to imipenem. Unlike other known carbapenems (meropenem, panipenem, biapenem, and BO-2727), which have reduced activity against imipenem-resist...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1995
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162548/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726503/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.386 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
